First therapy to treat pediatric MS approved in US

17th May 2018

Fingolimod has been approved by the US Food and Drug Administration (FDA) as a treatment for children…

Creative brief: Arab region awareness raising campaign

15th May 2018

MSIF is looking for an Arabic speaking experienced creative agency/consultant to develop a visual concept for an…

Japan MS Society hosts seventh annual seminar

8th May 2018

The Japan MS Society invited people affected by MS, MS professionals and the public to its seventh…

Event highlights from the Brazilian MS Association

8th May 2018

The Brazilian MS Association (ABEM) shares highlights from a recent cruise for people with MS, an informative…

Kiss Goodbye to MS campaign launch

8th May 2018

Fundraisers around the world unite to raise 1.5m USD for the global Kiss Goodbye to MS campaign.

Bringing Us Closer: World MS Day 2018

8th May 2018

World MS Day will take place on 30 May. The 2018 campaign is called Bringing Us Closer…

Winner of first Global MS Research Booster Award announced

8th May 2018

Benjamin Clarkson receives the first ever Global MS Research Booster Award, a unique initiative of MoveS, Stichting…

Highlights from MSIF’s 2018 Global Networking Meetings, Amsterdam

4th May 2018

Stichting MS Research welcomed the global MSIF movement in Amsterdam last month for the spring 2018 Global…

Eating fish may lower the risk of developing MS

26th April 2018

US study shows people who eat fish may be less likely to develop MS.

Mood and anxiety disorders linked to disability progression in MS

26th April 2018

New research shows psychiatric disorders are associated with the worsening of MS disability outcomes.

Interim AHSCT trial results released

26th April 2018

Interim results from one of the first randomised controlled trials comparing autologous haematopoietic stem cell transplant (AHSCT) to other…

Siponimod offers hope for people with secondary progressive MS

26th April 2018

A new, international clinical trial has shown that siponimod can slow progression in people with secondary progressive…